Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Dunn

Showing results (751-760 of 851) with videos related to

Pageof 86
Sort By:
Biochemistry|April 14, 2016
Synergistic Biomineralization Phenomena Created by a Combinatorial Nacre Protein Model SystemEric P Chang, Teresa Roncal-Herrero, Tamara Morgan, et al.
Drug and Alcohol Dependence|September 5, 2025
Craving for opioid and cannabis use among adults with chronic pain: Insights from a 30-day ecological momentary assessment studyJennifer D Ellis, Ashley E Chipoletti, Siny Tsang, et al.
Journal of the American College of Cardiology|July 11, 2020
Characteristics of Adults With Congenital Heart Defects in the United StatesMichelle Gurvitz, Julie E Dunn, Ami Bhatt, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|August 11, 2019
Cancer survivor perspectives on sharing patient-generated health data with central cancer registriesT G Smith, M E Dunn, K Y Levin, et al.
Biorxiv : the Preprint Server for Biology|March 10, 2025
Evidence for Functional Regulation of the KLHL3/WNK Pathway by O-GlcNAcylationJimin Hu, Duc T Huynh, Denise E Dunn, et al.
Molecular Pharmacology|June 28, 2007
The phosphoinositide-dependent kinase-1 inhibitor 2-amino-N-[4-[5-(2-phenanthrenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]phenyl]-acetamide (OSU-03012) prevents Y-box binding protein-1 from inducing epidermal growth factor receptorK To, Y Zhao, H Jiang, et al.
The European Respiratory Journal|November 21, 2015
Blood basophil activation is a reliable biomarker of allergic bronchopulmonary aspergillosis in cystic fibrosisYael Gernez, Jeffrey Waters, Bojana Mirković, et al.
Stem Cells (Dayton, Ohio)|March 15, 2012
Polo-like kinase 1 inhibition kills glioblastoma multiforme brain tumor cells in part through loss of SOX2 and delays tumor progression in miceCathy Lee, Abbas Fotovati, Joanna Triscott, et al.
Biochemistry|December 24, 1996
Protein engineering thrombin for optimal specificity and potency of anticoagulant activity in vivoM Tsiang, L R Paborsky, W X Li, et al.
Experimental and Clinical Psychopharmacology|July 20, 2023
Xylazine suppresses fentanyl consumption during self-administration and induces a unique sex-specific withdrawal syndrome that is not altered by naloxone in ratsShailesh N Khatri, Safiyah Sadek, Percell T Kendrick, et al.
Pageof 86

Showing results (751-760 of 851) with videos related to

Sort By:
Pageof 86
Biochemistry|April 14, 2016
Synergistic Biomineralization Phenomena Created by a Combinatorial Nacre Protein Model SystemEric P Chang, Teresa Roncal-Herrero, Tamara Morgan, et al.
Drug and Alcohol Dependence|September 5, 2025
Craving for opioid and cannabis use among adults with chronic pain: Insights from a 30-day ecological momentary assessment studyJennifer D Ellis, Ashley E Chipoletti, Siny Tsang, et al.
Journal of the American College of Cardiology|July 11, 2020
Characteristics of Adults With Congenital Heart Defects in the United StatesMichelle Gurvitz, Julie E Dunn, Ami Bhatt, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|August 11, 2019
Cancer survivor perspectives on sharing patient-generated health data with central cancer registriesT G Smith, M E Dunn, K Y Levin, et al.
Biorxiv : the Preprint Server for Biology|March 10, 2025
Evidence for Functional Regulation of the KLHL3/WNK Pathway by O-GlcNAcylationJimin Hu, Duc T Huynh, Denise E Dunn, et al.
Molecular Pharmacology|June 28, 2007
The phosphoinositide-dependent kinase-1 inhibitor 2-amino-N-[4-[5-(2-phenanthrenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]phenyl]-acetamide (OSU-03012) prevents Y-box binding protein-1 from inducing epidermal growth factor receptorK To, Y Zhao, H Jiang, et al.
The European Respiratory Journal|November 21, 2015
Blood basophil activation is a reliable biomarker of allergic bronchopulmonary aspergillosis in cystic fibrosisYael Gernez, Jeffrey Waters, Bojana Mirković, et al.
Stem Cells (Dayton, Ohio)|March 15, 2012
Polo-like kinase 1 inhibition kills glioblastoma multiforme brain tumor cells in part through loss of SOX2 and delays tumor progression in miceCathy Lee, Abbas Fotovati, Joanna Triscott, et al.
Biochemistry|December 24, 1996
Protein engineering thrombin for optimal specificity and potency of anticoagulant activity in vivoM Tsiang, L R Paborsky, W X Li, et al.
Experimental and Clinical Psychopharmacology|July 20, 2023
Xylazine suppresses fentanyl consumption during self-administration and induces a unique sex-specific withdrawal syndrome that is not altered by naloxone in ratsShailesh N Khatri, Safiyah Sadek, Percell T Kendrick, et al.
Pageof 86